ID   TTP_RAT                 Reviewed;         320 AA.
AC   P47973; Q54AH1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   24-JAN-2024, entry version 157.
DE   RecName: Full=mRNA decay activator protein ZFP36 {ECO:0000305};
DE   AltName: Full=TPA-induced sequence 11 {ECO:0000250|UniProtKB:P22893};
DE   AltName: Full=Tristetraprolin {ECO:0000250|UniProtKB:P26651};
DE   AltName: Full=Zinc finger protein 36 {ECO:0000312|RGD:620722};
DE            Short=Zfp-36 {ECO:0000250|UniProtKB:P22893};
GN   Name=Zfp36 {ECO:0000312|RGD:620722};
GN   Synonyms=Tis11 {ECO:0000303|PubMed:1511903},
GN   Ttp {ECO:0000250|UniProtKB:P26651};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1511903; DOI=10.1016/0378-1119(92)90202-z;
RA   Kaneda N., Oshima M., Chung S.Y., Guroff G.;
RT   "Sequence of a rat TIS11 cDNA, an immediate early gene induced by growth
RT   factors and phorbol esters.";
RL   Gene 118:289-291(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11129950; DOI=10.1023/a:1007172316657;
RA   Kaneda N., Murata T., Niimi Y., Minamiyama M.;
RT   "Cloning and characterization of the rat TIS11 gene.";
RL   Mol. Cell. Biochem. 213:119-126(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF LEU-3 AND LEU-10, AND DOMAIN.
RX   PubMed=12054509; DOI=10.1016/s0006-291x(02)00363-7;
RA   Murata T., Yoshino Y., Morita N., Kaneda N.;
RT   "Identification of nuclear import and export signals within the structure
RT   of the zinc finger protein TIS11.";
RL   Biochem. Biophys. Res. Commun. 293:1242-1247(2002).
RN   [5]
RP   RNA-BINDING.
RX   PubMed=27193233; DOI=10.1007/s00726-016-2261-9;
RA   Nowotarski S.L., Origanti S., Sass-Kuhn S., Shantz L.M.;
RT   "Destabilization of the ornithine decarboxylase mRNA transcript by the RNA-
RT   binding protein tristetraprolin.";
RL   Amino Acids 48:2303-2311(2016).
CC   -!- FUNCTION: Zinc-finger RNA-binding protein that destabilizes numerous
CC       cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by
CC       promoting their poly(A) tail removal or deadenylation, and hence
CC       provide a mechanism for attenuating protein synthesis
CC       (PubMed:27193233). Acts as an 3'-untranslated region (UTR) ARE mRNA-
CC       binding adapter protein to communicate signaling events to the mRNA
CC       decay machinery. Recruits deadenylase CNOT7 (and probably the CCR4-NOT
CC       complex) via association with CNOT1, and hence promotes ARE-mediated
CC       mRNA deadenylation. Functions also by recruiting components of the
CC       cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs. Self
CC       regulates by destabilizing its own mRNA (By similarity). Binds to 3'-
CC       UTR ARE of numerous mRNAs (PubMed:27193233). Binds also to ARE of its
CC       own mRNA. Plays a role in anti-inflammatory responses; suppresses tumor
CC       necrosis factor (TNF)-alpha production by stimulating ARE-mediated TNF-
CC       alpha mRNA decay and several other inflammatory ARE-containing mRNAs in
CC       interferon (IFN)- and/or lipopolysaccharide (LPS)-induced macrophages.
CC       Also plays a role in the regulation of dendritic cell maturation at the
CC       post-transcriptional level, and hence operates as part of a negative
CC       feedback loop to limit the inflammatory response. Promotes ARE-mediated
CC       mRNA decay of hypoxia-inducible factor HIF1A mRNA during the response
CC       of endothelial cells to hypoxia. Positively regulates early
CC       adipogenesis of preadipocytes by promoting ARE-mediated mRNA decay of
CC       immediate early genes (IEGs). Negatively regulates
CC       hematopoietic/erythroid cell differentiation by promoting ARE-mediated
CC       mRNA decay of the transcription factor STAT5B mRNA. Plays a role in
CC       maintaining skeletal muscle satellite cell quiescence by promoting ARE-
CC       mediated mRNA decay of the myogenic determination factor MYOD1 mRNA.
CC       Associates also with and regulates the expression of non-ARE-containing
CC       target mRNAs at the post-transcriptional level, such as MHC class I
CC       mRNAs. Participates in association with argonaute RISC catalytic
CC       components in the ARE-mediated mRNA decay mechanism; assists microRNA
CC       (miRNA) targeting ARE-containing mRNAs. May also play a role in the
CC       regulation of cytoplasmic mRNA decapping; enhances decapping of ARE-
CC       containing RNAs, in vitro. Involved in the delivery of target ARE-mRNAs
CC       to processing bodies (PBs). In addition to its cytosolic mRNA-decay
CC       function, affects nuclear pre-mRNA processing. Negatively regulates
CC       nuclear poly(A)-binding protein PABPN1-stimulated polyadenylation
CC       activity on ARE-containing pre-mRNA during LPS-stimulated macrophages.
CC       Also involved in the regulation of stress granule (SG) and P-body (PB)
CC       formation and fusion. Plays a role in the regulation of keratinocyte
CC       proliferation, differentiation and apoptosis. Plays a role as a tumor
CC       suppressor by inhibiting cell proliferation in breast cancer cells (By
CC       similarity). {ECO:0000250|UniProtKB:P22893,
CC       ECO:0000250|UniProtKB:P26651, ECO:0000269|PubMed:27193233}.
CC   -!- SUBUNIT: Associates with cytoplasmic CCR4-NOT and PAN2-PAN3 deadenylase
CC       complexes to trigger ARE-containing mRNA deadenylation and decay
CC       processes. Part of a mRNA decay activation complex at least composed of
CC       poly(A)-specific exoribonucleases CNOT6, EXOSC2 and XRN1 and mRNA-
CC       decapping enzymes DCP1A and DCP2. Associates with the RNA exosome
CC       complex. Interacts (via phosphorylated form) with 14-3-3 proteins;
CC       these interactions promote exclusion of ZFP36 from cytoplasmic stress
CC       granules in response to arsenite treatment in a MAPKAPK2-dependent
CC       manner and does not prevent CCR4-NOT deadenylase complex recruitment or
CC       ZFP36-induced ARE-containing mRNA deadenylation and decay processes.
CC       Interacts with 14-3-3 proteins; these interactions occur in response to
CC       rapamycin in an Akt-dependent manner. Interacts with AGO2 and AGO4.
CC       Interacts (via C-terminus) with CNOT1; this interaction occurs in a
CC       RNA-independent manner and induces mRNA deadenylation. Interacts (via
CC       N-terminus) with CNOT6. Interacts with CNOT6L. Interacts (via C-
CC       terminus) with CNOT7; this interaction occurs in a RNA-independent
CC       manner, induces mRNA deadenylation and is inhibited in a
CC       phosphorylation MAPKAPK2-dependent manner. Interacts (via
CC       unphosphorylated form) with CNOT8; this interaction occurs in a RNA-
CC       independent manner and is inhibited in a phosphorylation MAPKAPK2-
CC       dependent manner. Interacts with DCP1A. Interacts (via N-terminus) with
CC       DCP2. Interacts with EDC3. Interacts (via N-terminus) with EXOSC2.
CC       Interacts with heat shock 70 kDa proteins. Interacts with KHSRP; this
CC       interaction increases upon cytokine-induced treatment. Interacts with
CC       MAP3K4; this interaction enhances the association with SH3KBP1/CIN85.
CC       Interacts with MAPKAPK2; this interaction occurs upon skeletal muscle
CC       satellite cell activation. Interacts with NCL. Interacts with NUP214;
CC       this interaction increases upon lipopolysaccharide (LPS) stimulation.
CC       Interacts with PABPC1; this interaction occurs in a RNA-dependent
CC       manner. Interacts (via hypophosphorylated form) with PABPN1 (via RRM
CC       domain and C-terminal arginine-rich region); this interaction occurs in
CC       the nucleus in a RNA-independent manner, decreases in presence of
CC       single-stranded poly(A) RNA-oligomer and in a p38 MAPK-dependent-manner
CC       and inhibits nuclear poly(A) tail synthesis. Interacts with PAN2.
CC       Interacts (via C3H1-type zinc finger domains) with PKM. Interacts (via
CC       C3H1-type zinc finger domains) with nuclear RNA poly(A) polymerase.
CC       Interacts with PPP2CA; this interaction occurs in LPS-stimulated cells
CC       and induces ZFP36 dephosphorylation, and hence may promote ARE-
CC       containing mRNAs decay. Interacts (via C-terminus) with PRR5L (via C-
CC       terminus); this interaction may accelerate ZFP36-mediated mRNA decay
CC       during stress. Interacts (via C-terminus) with SFN; this interaction
CC       occurs in a phosphorylation-dependent manner. Interacts (via extreme C-
CC       terminal region) with SH3KBP1/CIN85 (via SH3 domains); this interaction
CC       enhances MAP3K4-induced phosphorylation of ZFP36 at Ser-59 and Ser-86
CC       and does not alter neither ZFP36 binding to ARE-containing transcripts
CC       nor TNF-alpha mRNA decay. Interacts with XRN1. Interacts (via C-
CC       terminus and Ser-179 phosphorylated form) with YWHAB; this interaction
CC       occurs in a p38/MAPKAPK2-dependent manner, increases cytoplasmic
CC       localization of ZFP36 and protects ZFP36 from Ser-179 dephosphorylation
CC       by serine/threonine phosphatase 2A, and hence may be crucial for
CC       stabilizing ARE-containing mRNAs. Interacts (via phosphorylated form)
CC       with YWHAE. Interacts (via C-terminus) with YWHAG; this interaction
CC       occurs in a phosphorylation-dependent manner. Interacts with YWHAH;
CC       this interaction occurs in a phosphorylation-dependent manner.
CC       Interacts with YWHAQ; this interaction occurs in a phosphorylation-
CC       dependent manner. Interacts with (via C-terminus) YWHAZ; this
CC       interaction occurs in a phosphorylation-dependent manner. Does not
CC       interact with SH3KBP1. Interacts (via P-P-P-P-G repeats) with GIGYF2;
CC       the interaction is direct (By similarity).
CC       {ECO:0000250|UniProtKB:P22893, ECO:0000250|UniProtKB:P26651}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12054509}. Cytoplasm
CC       {ECO:0000269|PubMed:12054509}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:P22893}. Cytoplasm, P-body
CC       {ECO:0000250|UniProtKB:P22893}. Note=Shuttles between nucleus and
CC       cytoplasm in a CRM1-dependent manner (PubMed:12054509). Localized
CC       predominantly in the cytoplasm in a p38 MAPK- and YWHAB-dependent
CC       manner. Colocalizes with SH3KBP1 and MAP3K4 in the cytoplasm. Component
CC       of cytoplasmic stress granules (SGs). Localizes to cytoplasmic stress
CC       granules upon energy starvation. Localizes in processing bodies (PBs).
CC       Excluded from stress granules in a phosphorylation MAPKAPK2-dependent
CC       manner. Shuttles in and out of both cytoplasmic P-body and SGs (By
CC       similarity). {ECO:0000250|UniProtKB:P22893,
CC       ECO:0000250|UniProtKB:P26651, ECO:0000269|PubMed:12054509}.
CC   -!- DOMAIN: The C3H1-type zinc finger domains are necessary for ARE-binding
CC       activity. {ECO:0000250|UniProtKB:P26651}.
CC   -!- PTM: Phosphorylated. Phosphorylation at serine and/or threonine
CC       residues occurs in a p38 MAPK- and MAPKAPK2-dependent manner.
CC       Phosphorylated by MAPKAPK2 at Ser-53 and Ser-179; phosphorylation
CC       increases its stability and cytoplasmic localization, promotes binding
CC       to 14-3-3 adapter proteins and inhibits the recruitment of cytoplasmic
CC       CCR4-NOT and PAN2-PAN3 deadenylase complexes to the mRNA decay
CC       machinery, thereby inhibiting ZFP36-induced ARE-containing mRNA
CC       deadenylation and decay processes. Phosphorylation by MAPKAPK2 does not
CC       impair ARE-containing RNA-binding. Phosphorylated in a MAPKAPK2- and
CC       p38 MAPK-dependent manner upon skeletal muscle satellite cell
CC       activation; this phosphorylation inhibits ZFP36-mediated mRNA decay
CC       activity, and hence stabilizes MYOD1 mRNA. Phosphorylated by MAPK1 upon
CC       mitogen stimulation. Phosphorylated at Ser-59 and Ser-86; these
CC       phosphorylations increase in a SH3KBP1-dependent manner. Phosphorylated
CC       at serine and threonine residues in a pyruvate kinase PKM- and p38
CC       MAPK-dependent manner. Phosphorylation at Ser-53 may participate in the
CC       PKM-mediated degradation of ZFP36 in a p38 MAPK-dependent manner.
CC       Dephosphorylated by serine/threonine phosphatase 2A at Ser-179.
CC       {ECO:0000250|UniProtKB:P22893, ECO:0000250|UniProtKB:P26651}.
CC   -!- PTM: Ubiquitinated; pyruvate kinase (PKM)-dependent ubiquitination
CC       leads to proteasomal degradation through a p38 MAPK signaling pathway.
CC       {ECO:0000250|UniProtKB:P26651}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63369; CAA44970.1; -; mRNA.
DR   EMBL; AB025017; BAB12432.1; -; Genomic_DNA.
DR   EMBL; BC060308; AAH60308.1; -; mRNA.
DR   PIR; JC1255; JC1255.
DR   RefSeq; NP_579824.2; NM_133290.3.
DR   AlphaFoldDB; P47973; -.
DR   SMR; P47973; -.
DR   STRING; 10116.ENSRNOP00000073413; -.
DR   PhosphoSitePlus; P47973; -.
DR   PaxDb; 10116-ENSRNOP00000026661; -.
DR   GeneID; 79426; -.
DR   KEGG; rno:79426; -.
DR   UCSC; RGD:620722; rat.
DR   AGR; RGD:620722; -.
DR   CTD; 7538; -.
DR   RGD; 620722; Zfp36.
DR   eggNOG; KOG1677; Eukaryota.
DR   InParanoid; P47973; -.
DR   OrthoDB; 23913at2759; -.
DR   PhylomeDB; P47973; -.
DR   Reactome; R-RNO-450513; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA.
DR   PRO; PR:P47973; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030014; C:CCR4-NOT complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; ISS:UniProtKB.
DR   GO; GO:0019957; F:C-C chemokine binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0070063; F:RNA polymerase binding; ISS:UniProtKB.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; ISS:UniProtKB.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; ISS:UniProtKB.
DR   GO; GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0035278; P:miRNA-mediated gene silencing by inhibition of translation; ISS:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:0051028; P:mRNA transport; ISS:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISO:RGD.
DR   GO; GO:0045647; P:negative regulation of erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:1902037; P:negative regulation of hematopoietic stem cell differentiation; ISO:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; ISS:UniProtKB.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISO:RGD.
DR   GO; GO:1904246; P:negative regulation of polynucleotide adenylyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032897; P:negative regulation of viral transcription; ISS:UniProtKB.
DR   GO; GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISO:RGD.
DR   GO; GO:0031086; P:nuclear-transcribed mRNA catabolic process, deadenylation-independent decay; ISS:UniProtKB.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; ISO:RGD.
DR   GO; GO:0038066; P:p38MAPK cascade; ISS:UniProtKB.
DR   GO; GO:1901835; P:positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA; ISS:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:1904582; P:positive regulation of intracellular mRNA localization; ISS:UniProtKB.
DR   GO; GO:2000637; P:positive regulation of miRNA-mediated gene silencing; ISS:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; ISS:UniProtKB.
DR   GO; GO:1902172; P:regulation of keratinocyte apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0010837; P:regulation of keratinocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0043488; P:regulation of mRNA stability; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; ISS:UniProtKB.
DR   GO; GO:0009611; P:response to wounding; ISS:UniProtKB.
DR   GO; GO:0050779; P:RNA destabilization; ISO:RGD.
DR   Gene3D; 4.10.1000.10; Zinc finger, CCCH-type; 2.
DR   InterPro; IPR045877; ZFP36-like.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR036855; Znf_CCCH_sf.
DR   PANTHER; PTHR12547; CCCH ZINC FINGER/TIS11-RELATED; 1.
DR   PANTHER; PTHR12547:SF58; MRNA DECAY ACTIVATOR PROTEIN ZFP36; 1.
DR   Pfam; PF00642; zf-CCCH; 2.
DR   SMART; SM00356; ZnF_C3H1; 2.
DR   SUPFAM; SSF90229; CCCH zinc finger; 2.
DR   PROSITE; PS50103; ZF_C3H1; 2.
PE   1: Evidence at protein level;
KW   Cytoplasm; Developmental protein; DNA-binding; Exosome; Metal-binding;
KW   mRNA transport; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ribonucleoprotein; Transport; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..320
FT                   /note="mRNA decay activator protein ZFP36"
FT                   /id="PRO_0000089165"
FT   REPEAT          64..68
FT                   /note="P-P-P-P-G"
FT   REPEAT          191..195
FT                   /note="P-P-P-P-G"
FT   REPEAT          212..216
FT                   /note="P-P-P-P-G"
FT   ZN_FING         96..124
FT                   /note="C3H1-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   ZN_FING         134..162
FT                   /note="C3H1-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          1..167
FT                   /note="Necessary for localization of ARE-containing mRNAs
FT                   to processing bodies (PBs)"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   REGION          1..93
FT                   /note="Necessary and sufficient for the association with
FT                   mRNA decay enzymes and mRNA decay activation"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   REGION          1..15
FT                   /note="Necessary for nuclear export"
FT                   /evidence="ECO:0000269|PubMed:12054509"
FT   REGION          17..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          66..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          88..161
FT                   /note="Necessary for nuclear localization"
FT                   /evidence="ECO:0000269|PubMed:12054509"
FT   REGION          90..166
FT                   /note="Necessary for RNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   REGION          93..320
FT                   /note="Necessary for localization of ARE-containing mRNAs
FT                   to processing bodies (PBs)"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   REGION          96..187
FT                   /note="Necessary for interaction with PABPN1"
FT                   /evidence="ECO:0000250|UniProtKB:P22893"
FT   REGION          167..320
FT                   /note="Necessary for mRNA decay activation"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   REGION          180..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          306..320
FT                   /note="Interaction with CNOT1"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   COMPBIAS        19..50
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        66..85
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        274..288
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         53
FT                   /note="Phosphoserine; by MAPKAPK2"
FT                   /evidence="ECO:0000250|UniProtKB:P22893"
FT   MOD_RES         59
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22893"
FT   MOD_RES         85
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         179
FT                   /note="Phosphoserine; by MAPKAPK2"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         221
FT                   /note="Phosphoserine; by MAPK1; in vitro"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         251
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P22893"
FT   MOD_RES         270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MOD_RES         317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26651"
FT   MUTAGEN         3
FT                   /note="L->A: Inhibits nucleus export."
FT                   /evidence="ECO:0000269|PubMed:12054509"
FT   MUTAGEN         10
FT                   /note="L->A: Inhibits nucleus export."
FT                   /evidence="ECO:0000269|PubMed:12054509"
SQ   SEQUENCE   320 AA;  33654 MW;  CFC597F3C7E5CA76 CRC64;
     MDLSAIYESL MSMSHDLSPD HGGTESSGGL WNINSSDSIP SGVTSRLTGR STSLVEGRSC
     SWVPPPPGFA PLAPRPGPEL SPSPTSPTAT PTTSSRYKTE LCRTYSESGR CRYGAKCQFA
     HGPGELRQAN RHPKYKTELC HKFYLQGRCP YGSRCHFIHN PTEDLALPGQ PHVLRQSISF
     SGLPSGRRTS PPPPGFSGPS LSSCSFSPSS SPPPPGDLPL SPSAFSAAPG TPVSRRDPTP
     ACCPSCRRST TPSTIWGPLG GLARSPSAHS LGSDPDDYAS SGSSLGGSDS PVFEAGVFGP
     PQPPAPPRRL PIFNRISVSE
//
